Abstract
The renin-angiotensin system is thought to have a key role in the structural remodeling of the left ventricle that accompanies healing after acute myocardial infarction and is an important determinant of long-term prognosis. Does a direct renin inhibitor provide additive benefit to patients already treated with βblockers and either angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers?
Original language | English (US) |
---|---|
Pages (from-to) | 248-249 |
Number of pages | 2 |
Journal | Nature Reviews Cardiology |
Volume | 8 |
Issue number | 5 |
DOIs | |
State | Published - May 2011 |